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Administration of intracoronary verapamil via self-made perfusion balloon
to Treat No-Reﬂow Phenomenon following PCI in patients with Acute
Coronary Syndromes
Jincheng Guo, Wenming Chen, Guozhong Wang, Fuli Zhu, Rong Xu,
Zhenghai Zhang, Shunjin Gan
Beijing Luhe hospital, Capital Medical University
OBJECTIVES To evaluate the efﬁcacy and safety of intracoronary
administration of verapamil through self-made perfusion balloon,
with 2w4 holes punctured by needle at the end of a rapid exchange
balloon, to treat impaired blood ﬂow (no/slow reﬂow phenomenon,
NSF) in patients with acute coronary syndrome (ACS) during percu-
taneous coronary intervention (PCI).
METHODS This retrospective study was composed of 129 patients
who presented with ACS between January 2013 and August 2014, and
developed NSF during subsequent PCI. Of the 129 patients, primary
PCI was performed in 75 patients, rescue PCI in 1 patient and elective
PCI in 53 patients. NSF was observed in 90 patients (69.8%) at post-
stenting and 39 patients (30.2%) at postdilation. Verapamil, 200 to
1000mg by slow manually intracoronary infusion for at least 1min, was
given via the self-made perfusion balloon distal to the angioplasty
site, Where the blood ﬂow was the slowest. The primary end points
included ﬂow improvement in Thrombolysis In Myocardial Infarction
[TIMI] ﬂow grade, corrected thrombolysis in myocardial infarction
frame count (CTFC) and TIMI myocardial perfusion grade(TMP), ST
segment resolution in primary PCI patients after administration of
the verapamil and in-hospital and 30-day major adverse cardiac
events (MACE) including death, myocardial infarction, repeat
revascularization.
RESULTS There was a signiﬁcant improvement of TIMI-3 ﬂow, TMP-
0w1 and CTFC after intracoronary administration of verapamil (89.9%
vs 37.2%, p <0.001; 76.0% vs 11.6%, p <0.001; 6627 frames vs 3721
frames, p <0.001, respectively). At end of the procedure, TIMI 3 ﬂow
was achieved in 114 patients (88.4%), TMP 2w3 ﬂow in 98 patients
(76.0%). The rate for complete, partial and no ST segment resolution
was 31.6%, 26.3% and 42.1%, respectively. Transient complete atrio-
ventricular block occurred during verapamil injection to right coro-
nary artery in 2 patients, which disappeared after atropine. There was
no MACE in-hospital and 30-day except for 1 patient died of cardio-
genic shock in hospital.
CONCLUSIONS Intracoronary verapamil via self-made perfusion
balloon is an effective, safe treatment of NSF associated with PCI in
ACS patients.GW26-e4477
Safety and Efﬁcacy of using a single transRAdial MAC guiding catheter for
coronary angiograPhy and Intervention in patients with STE-MyocarDial
infarction (RAPID)
Jincheng Guo, Wenming Chen, Guozhong Wang, Rong Xu, Zijing Liu,
Shunjin Gan, Libin Zhang
Beijing Luhe hospital, Capital Medical University
OBJECTIVES Coronary intervention using transradial approach is
common worldwide. It is normally necessary to use one diagnostic
catheter and guiding catheter in primary percutaneous coronary
intervention (PCI) for ST elevation myocardial infarction (STEMI). It is
unknown whether using a single guiding catheter for both nonculprit
and culprit vessel angiography and intervention during transradial
primary PCI is feasible. The aim of this study is to investigate the
safety and feasibility of using a single guiding catheter (MAC 3.5) for
left and right coronary angiography and intervention in patients with
STEMI.
METHODS This was a single-center, prospective, randomized study
conducted from August 2011 to April 2014, 360 patients with STEMI
indicated for transradial primary PCI performed were randomized into
two groups: MAC group (180 cases) consisted of patients who under-
went coronary angiography and primary PCI by using a single guiding
catheter (MAC3.5). Control group (180 cases) included patients who
ﬁrst underwent coronary angiography with 5FTiger diagnostic cath-
eter followed by guiding catheter selection at the operator’s discretion
for intervention. The primary outcomes were catheterization labora-
tory door to balloon time (C2B). The secondary outcomes were major
adverse cardiac events (MACE) including composite of cardiac death,myocardial infarction target vessel revascularization, target lesion
revascularization and stent thrombosis at 30 days and 6 months.
Analyses were by intention to treat.
RESULTS Baseline patient characteristics were similar between the
MAC group and control group. the sheath placement time (2.21.8 min
vs 1.71.3 min), the PCI procedural success rate(91.7% vs 91.7%), door
to balloon time(87.139.4 min vs 85.635.0 min) and contrast con-
sumption (10337 ml vs 11041 ml) in the two groups were not sta-
tistically signiﬁcant(p >0.05). Compare with the Control group, C2B
time, total procedure time and the overall ﬂuoroscopy time were
signiﬁcantly lower in MAC Group (17.15.5 min vs 18.64 4.20 min,
p<0.001; 32.115.4 min vs 35.912.9 min, p ¼0.013; 8.9 3.8min vs 9.9
4.8 min, p ¼0.032, respectively). The 30-day MACE rates were 2.8%
and 2.2% in the MAC and control groups (p >0.05). No signiﬁcant
difference in MACE was observed at 6-month (5.6% vs 5.0%, p >0.05).
CONCLUSIONS A single transradial MAC 3.5 guiding catheter for
coronary angiography and intervention seems to be a better option for
patients with STEMI for whom primary PCI is planned. It can shorten
C2B time, procedure time and ﬂuoroscopy time. Further study is
required to determine whether this strategy can favorably affect
clinical outcomes.
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Establishment of an experimental angiographic slow coronary ﬂow model
by microsphere embolism in pigs
Yupeng Bai, Liqun Hu, Delong Yu, Sheng Peng, Xiaogang Liu,
Mingjing Zhang, Ye Gu
Department of Cardiology, Puai Hospital, Huazhong University of
Science and Technology
OBJECTIVES No-reﬂow or slow-ﬂow post revascularization remains a
challenge in interventional cardiology. Till now, there is no large
animal model with angiographic evidence of slow ﬂow. The objective
of this study is to establish a swine slow ﬂow model with angiographic
evidence mimicking the clinical situation.
METHODS In closed chest porcine, slow reﬂow was established in 8
pigs by repeated small amount left anterior descending coronary in-
jection of 40 mm microsphere injection till the appearance of angio-
graphic slow ﬂow: Thrombolysis in Myocardial Infarction (TIMI) frame
count (TFC)>40. TFC and TIMI myocardial perfusion grade (TMPG)
were determined in coronary angiography examinations (CAG). CAG
and left ventriculography were repeated at 4 weeks post procedure.
RESULTS One pig died at 2 days post microsphere injection and au-
topsy evidenced lung edema in this animal, another pig received
temporary mechanical ventilation due to breathing depression post
anesthesia and recovered. TFC was signiﬁcantly increased at the time
of establishment of no-reﬂow compared to baseline (59.819.4 vs.
15.83.4, p<0.05) and returned to baseline value (18.22.3) at 4 weeks
post procedure. Left ventricular (LV) end-diastolic volume (32.84.2
vs. 24.43.7 ml, p<0.05) and LV end-diastolic pressure (14.31.2 vs.
7.83.6mmHg, p<0.05) were higher, LV systolic pressure (1239 vs.
14715mmHg, p<0.05) and ejection fraction (585 vs. 685%,
p<0.05) were lower at 4 weeks post procedure compared to baseline
values.
CONCLUSIONS Angiographic no-reﬂow could be reliably induced in
porcine by coronary microsphere injection. This model may support
investigation on underlying mechanisms and new therapy options for
slow ﬂow phenomenon.GW26-e4529
Very Long-term Outcomes of Percutaneous Coronary Intervention with
Drug-eluting Stents versus Coronary Artery Bypass Grafting for Patients
with Unprotected Left Main Coronary Artery Disease
Fang Chen
Department of Cardiology, Beijing An Zhen Hospital, Capital Medical
University and Beijing Institute of Heart Lung and Blood Vessel
Disease, Beijing
OBJECTIVES This study aimed at comparing the long-term (>5 years)
outcomes of patients with unprotected left main coronary artery
(ULMCA) disease underwent percutaneous coronary intervention
(PCI) with drug-eluting stents (DES) and coronary-artery bypass
grafting (CABG).
METHODS All consecutive patients with ULMCA disease treated with
DES implantation versus CABG in our center, between January 2003 to
July 2009, were screened for analyzing. A propensity score analysis
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groups.
RESULTS 922 patients with ULMCA disease were ﬁnally enrolled for
the analyses: 465 were treated with DES implantation and 457 with
CABG. During the median follow-up of 7.1 years (interquartile range
5.3 to 8.2 years), no difference was found between PCI and CABG in
the occurrence of death (adjusted hazard ratio [HR]: 0.791; 95% con-
ﬁdence interval [CI]: 0.516 to 1.212; p¼0.282) and the composite end
point of cardiac death, MI and stroke (adjusted HR: 0.825; 95% CI:
0.576 to 1.182; p¼0.294). Rates of major adverse cardiac and cere-
brovascular events were signiﬁcantly higher in the PCI group
(adjusted HR: 1.394; 95% CI: 1.070 to 1.817; p¼0.014), in large part
because of the signiﬁcantly higher rate of repeat revascular-
ization(adjusted HR: 2.368; 95% CI: 1.653 to 3.392; p < 0.001). PCI was
correlated with lower occurrence of stroke (adjusted HR: 0.348; 95%
CI: 0.171 to 0.707; p ¼ 0.004).
CONCLUSIONS During a median follow-up of 7.1 years (IQR 5.3 to 8.2
years), there was still no difference in rate of death between PCI with
DES implantation and CABG in ULMCA lesions in this single-center
experience. CABG group was observed to have signiﬁcantly lower
rates of repeat revascularization but higher stroke rates compared
with PCI.
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Recanalization of coronary chronic total occlusion and its effects on
myocardial perfusion and long term outcome
Jingjing Wang, Luyue Gai, Qi Wang, Xue Zhai, Longtao Guan
Department of Cardiology, Chinese PLA General Hospital
OBJECTIVES The recanalization of the coronary chronic total occlu-
sion (CTO) is also not equal to the improved left ventricular function.
The present study will analyze what factors are contributing to suc-
cessful recanalization, the long term clinical outcomes and the effects
on myocardial salvage.
METHODS The patients who underwent coronary angiography (CAG)
from 2008 to 2013 were consecutively enrolled. The patients were
divided into 3 groups, the total occlusion and stenosis groups (group 1);
total occlusion myocardial perfusion group (group 2); CTO PCI
group (group 3). In the group 1 comparison was made between total
occlusion and high grade stenosis and the patients were followed for
the major adverse cardiovascular events. In the group 2 patients were
divided into total occlusion and stenosis. The SPECT summed rest
score, CAG indices (Syntax score, total MPG and MPGArea), echo-
cardiography indices (LVED and EF) were calculated. In the group 3,
559 CTO patients were divided into successful and unsuccessful
recanalization. The MPG, Bridge Point, Retrograde MPG, LVED and EF
were calculated.
RESULTS In the group 1, 253 total occlusion and 629 stenosis were
included. No difference in clinical characters was found between
total occlusion and stenosis except Syntax score. The MACE was
signiﬁcantly higher in total occlusion than in stenosis (P<0.05). No
difference in MACE among PCI, CABG and medicine treatments. In
the group 2 there were 111 patients who underwent SPECT and
CAG, of them 41 had total occlusion and 70 had stenosis. The total
occlusion had signiﬁcantly larger SRS, higher SYNTAX score,
reduced total MPG and MPGArea, enlarged LVED and reduced EF
(P<0.05). Stepwise multivariate analysis showed that the SRS were
independently correlated with EF, total occlusion and sex. In the
group 3, 559 CTO attempted PCI. The success rate was 67%.
Stepwise multivariate analysis showed age, unfavorite CTO and
higher J-score predicted unsuccessful recanalization. After suc-
cessful PCI there were 175 MPG2-3 and 99 MPG0-1. Low MPG
accounted for 36% and had low Bridge Point, low Retrograde MPG
and increased LVED (P<0.05). There were 190 Bridge Point 0-1 and
369 Bridge Point 2-3. Low Bridge Point accounted for 34%. After
PSmatch we found that low Bridge Point were correlated with
complex CTO, high J-score, Retrograde MPG, low EF and enlarged
LVED (P<0.05)
CONCLUSIONS Medication and CABG have similar clinical outcome
irrespective of CTO or stenosis. But CTO PCI may have poor clinical
outcome in comparison with stenosis. In CTO PCI the artery integrity
damage is more than stenosis. The myocardial perfusion and left
ventricular function are poor in the CTO patients. MPG, total MPG,
Bridge Point, EF and LVED are useful predictors of myocardial re-
covery after successful recanalization. Age, complex CTO and J-Score
are 3 main anatomic factors affecting recanalization. MPG and Bridge
Point help predict viability after recanalization.GW26-e1571
Efﬁcacy and safety of 6-month dual antiplatelet therapy for more than
75 year old patients having BUMA implantation
Jieyun Liu, Zhenjun Wang, Wen Yang, Chenchen Li, Lei Qin
The Kaifeng central Hospital
OBJECTIVES 12-month dual antiplatelet therapy (DAPT) is recom-
mended after implantation of drug-eluting stents (DESs) in patients
with coronary heart disease. BUMA is a new drug-eluting stent with
two different functional coating layers, and More than 75 year old
patients have more complications like bleeding and gastrointestinal
intolerance. The time is not clear for elderly patients with BUMA
implantation.
METHODS We reviewed the data of 242 consecutive more than 75 year
old patients who had BUMA implantation four years ago and
completed 6-month DAPT. They were divided into two groups
randomly: 6-month and 12-month DAPT groups. The efﬁcacy (a
composite incidence of cardiac death, myocardial infarction and
target vessel revascularization) and safety (incidences of bleeding,
gastrointestinal trouble and drug discontinuation) were compared
with two groups.
RESULTS 242 patients included in the analysis, 118 were 6-month
DAPT group, 124were 12-month DAPT group. The mean follow-up
duration was 241.8 months after BUMA implantation. The age,
history of hypertension and stroke, BMI, SBP, DBP, high-density
lipoprotein-cholesterol (HDL-C), triglycerides (TG), fasting blood
glucose (FBG), estimated glomerular ﬁltration rate (eGFR), at baseline
did not differ signiﬁcantly between the two groups. The rates of multi-
vessel lesions, prior MI, hemoglobin A1C (HbA1c) and low-density
lipoprotein cholesterol were no difference signiﬁcantly in two groups.
There was no signiﬁcant difference in the overall composite incidence
of cardiac death, myocardial infarction and target vessel revasculari-
zation in two groups at one years after PCI. The rates of bleeding
(especially minor bleeding), gastrointestinal trouble, drug discontin-
uation and any blood transfusion were markedly lower in the 6-month
DAPT group than 12-month DAPT group (2.54%vs4.84%;4.24%
vs6.45%;5.09%vs8.06%;0.85%vs2.42%, P<0.05).
CONCLUSIONS 6-month DAPT may be more preferable to more than
75 year old patients who have undergone BUMA implantation,
because of it’s efﬁcacy and safety.GW26-e4527
The importance of serial measurement of platelet aggregation in long-term
dual antiplatelet therapy following drug eluting stent implantation
Fang Chen
Department of Cardiology, Beijing An Zhen Hospital, Capital Medical
University and Beijing Institute of Heart Lung and Blood Vessel
Disease, Beijing
OBJECTIVES Dual antiplatelet therapy (DAPT) and the response to
clopidogrel are two pivotal issues impacting on the use of drug-
eluting stents (DESs). Consequently, we analyzed the combined in-
ﬂuence of these factors to evaluate their long term effect in patients
undergoing DES implantation.
METHODS Platelet aggregation was serially measured by light trans-
mission aggregometry in all eligible patients during the course of
treatment with DAPT, and the mean platelet aggregation level of each
participant was calculated. Based on the duration of DAPT and the
mean platelet aggregation level, all the enrolled patients were then
divided into four groups. The primary endpoint was a composite of
all-cause death, nonfatal myocardial infarction (MI), stent thrombosis,
unexpected repeat revascularization, and stroke.
RESULTS We analyzed 1,245 suitable patients in this study. These
were divided into group A (12 month DAPT & low platelet aggregation
level) with 204 subjects, group B (>12 month DAPT & high platelet
aggregation level) with 419 subjects, group C (12 month DAPT & high
platelet aggregation level) with 289 subjects, and group D (>12 month
DAPT & low platelet aggregation level) with 333 subjects. Compared
with all other groups, group D was associated with a decreased inci-
dence of primary endpoints [HR 0.485, 95%CI (0.25–0.96); P ¼ 0.038].
When the Cox proportional hazards model was further tested with D
group as the reference category within the same group, groups B and C
were associated with increased incidence of primary endpoints [HR
2.26, 95%CI (1.10–4.68); P ¼ 0.0273] and [HR 2.31, 95%CI (1.03–5.18);
P ¼ 0.0413]. Their respective multivariate Cox proportional hazards
regressions conﬁrmed these trends.
